Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study

BACKGROUND: Recently developed buprenorphine depot injections have the potential to reduce risk for diversion and misuse, and to increase adherence with fewer visits for supervised intake. However, it is unclear how patients perceive this new form of medication. The purpose of this study was to expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Björn, Flensburg, Olivia Liahaugen, Capusan, Andrea Johansson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131643/
https://www.ncbi.nlm.nih.gov/pubmed/35614466
http://dx.doi.org/10.1186/s13011-022-00474-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131643/
https://www.ncbi.nlm.nih.gov/pubmed/35614466
http://dx.doi.org/10.1186/s13011-022-00474-2

Ejemplares similares